Previous Article | Next Article 
Journal of Clinical Microbiology, May 2000, p. 2021-2022, Vol. 38, No. 5
0095-1137/00/$04.00+0
LETTERS TO THE EDITOR
Heat-Labile Serotyping of Two Campylobacter jejuni
Strains Isolated from Patients with Guillain-Barré
Syndrome and Belonging to Serotype O19 (Penner)
 |
LETTER |
Misawa et al. (3) recently reported a PCR-based method
for differentiating Campylobacter serotype O19 strains from
non-O19 strains. In another study (2), the same
investigators used restriction fragment length polymorphism analysis of
flaA genes and random amplified polymorphic DNA analysis of
C. jejuni strains to conclude that all serotype O19 strains
are closely related, regardless of their geographic origins,
heat-labile (HL) serotype, or association with Guillain-Barré
syndrome (GBS). In both studies, these researchers described a pair of
C. jejuni isolates of Penner serotype O19 (OH4382 and
OH4384) which were originally recovered from two Japanese siblings
suffering from GBS (1) and characterized as HL serotype 7. The other C. jejuni serotype O19 GBS strains belonged to
either serotype HL77 or HL84 (2, 3).
To understand how strains that appeared to be clonal could have
different HL antigens, we further investigated the HL antigens of
C. jejuni strains OH4382 and OH4384. Whereas strains OH4382 and OH4384 did not appear to agglutinate in serotyping antiserum specific for HL type 7, they both agglutinated when HL typing antisera
to types 77 and 84 were tested. These slide agglutination results were
confirmed with an indirect whole-cell enzyme-linked immunosorbent assay
(ELISA) in which both strains reacted with anti-HL77 and anti-HL84
antisera but failed to react with anti-HL7 antiserum.
To confirm the results described above, antisera to both C. jejuni OH4382 and C. jejuni OH4384 were prepared in
rabbits. After absorption of the antisera with a formalin-inactivated,
whole-cell suspension of an unrelated C. jejuni standard
strain (Penner O3:HL36) to remove antibodies to the common surface
components on the Campylobacter organisms, we tested the
absorbed antisera against HL type strains 7, 77, and 84 by an indirect
whole-cell ELISA (Fig. 1). The results verified that C. jejuni strains OH4382 and OH4384 do not
contain specific surface antigens related to HL type 7 but do possess surface components that induce antibodies to react specifically with HL
serostrains 77 and 84.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Titration of anti-OH4382 antiserum against a homologous
patient isolate (OH4382) and heterologous T7, T77, T84, and O3:HL36
serostrains by indirect whole-cell ELISA. OD, optical density.
|
|
To better understand the serological relationship of HL77 and HL84 type
strains, we used a standard method (4) to determine their
heat-stable (HS) O antigens. While C. jejuni HS O19 strains are not particularly common, it was surprising and unusual to observe
that both the HL77 and HL84 type strains were found to possess the HS
O:19 antigen. After removal of the anti-O19 antibodies by absorption
with O19 lipopolysaccharide-sensitized red blood cells, anti-OH4382 and
anti-OH4384 antisera still contained antibodies that reacted with the
HL type strains 77 and 84, indicating the presence of HL77 and HL84
antigens on both C. jejuni OH4382 and OH4384.
Our serological studies provide further evidence that C. jejuni strains of Penner serotype O19 appear to be clonal or
closely related in that they share common HS O and HL surface antigens.
 |
REFERENCES |
| 1.
|
Aspinall, G. O.,
A. G. McDonald,
H. Pang,
L. A. Kurjanczyk, and J. L. Penner.
1994.
Lipopolysaccharides of Campylobacter jejuni serotype O19: structures of core oligosaccharide regions from serostrain and two bacterial isolates from patients with Guillain-Barré Syndrome.
Biochemistry
33:241-249[CrossRef][Medline].
|
| 2.
|
Fujimoto, S.,
B. M. Allos,
N. Misawa,
C. M. Patton, and M. J. Blaser.
1997.
Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré Syndrome.
J. Infect. Dis.
176:1105-1108[Medline].
|
| 3.
|
Misawa, N.,
B. M. Allos, and M. J. Blaser.
1998.
Differentiation of Campylobacter jejuni serotype O19 strains from non-O19 strains by PCR.
J. Clin. Microbiol.
36:3567-3573[Abstract/Free Full Text].
|
| 4.
|
Penner, J. L., and J. N. Hennessy.
1980.
Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens.
J. Clin. Microbiol.
12:732-737[Abstract/Free Full Text].
|
| | | | |
Raymond S. W. Tsang
Patrick Frosk
Wendy M. Johnson
Bureau of Microbiology LCDC Health Canada 1015 Arlington St. Winnipeg, MB, Canada R3E 3R2
|
 |
AUTHORS' REPLY |
Our classification of the HL type of the C. jejuni strains
from Japanese sisters with Guillain-Barré syndrome was based
entirely on the previous (1, 3) characterization. Tsang et
al. now provide important evidence that the strains actually possess
HL77 and HL84 antigens and not HL7 antigens. In this regard, the
Japanese strains resemble O19 strains from other parts of the world
(2), and thus the study of Tsang et al. provides further
phenotypic evidence consistent with clonal characteristics of O19
strains. The biochemical basis of the C. jejuni HL antigens
is not defined. For certain serotypes, it is related to flagellar
antigens, but for most types the basis is not known. The study of Tsang
et al. also shows that HL77 and HL84 share important antigenic
determinants, which also is consistent with clonality of the O19
strains. An important next step will be to define the chemical and
structural basis of the HL77 and HL84 antigens of the O19 strains.
 |
REFERENCES |
| 1.
|
Aspinall, G. O.,
A. G. McDonald,
H. Pang,
L. A. Kurjanczyk, and J. L. Penner.
1994.
Lipopolysaccharides of Campylobacter jejuni serotype O19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with Guillain-Barré Syndrome.
Biochemistry
33:241-249.
|
| 2.
|
Misawa, N.,
B. M. Allos, and M. J. Blaser.
1998.
Differentiation of Campylobacter jejuni serotype O19 strains from non-O19 strains by PCR.
J. Clin. Microbiol.
36:3567-3573.
|
| 3.
|
Yuki, N.,
S. Sato,
S. Fujimoto,
S. Yamada,
Y. Tsujino,
A. Kinoshita, and T. Itoh.
1992.
Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré Syndrome.
Muscle Nerve
15:968-969[Medline].
|
| | | | |
N. Misawa
B. M. Allos
M. J. Blaser
Faculty of Agriculture Veterinary Public Health Miyazaki University Miyazaki 889-2192, Japan
|
Journal of Clinical Microbiology, May 2000, p. 2021-2022, Vol. 38, No. 5
0095-1137/00/$04.00+0
This article has been cited by other articles:
-
Misawa, N., Kawashima, K., Kondo, F., Ban Mishu Allos, , Blaser, M. J.
(2001). DNA diversity of the wla gene cluster among serotype HS:19 and non-HS:19 Campylobacter jejuni strains. Innate Immunity
7: 349-358
[Abstract]
-
Tsang, R. S. W., Figueroa, G., Bryden, L., Ng, L.-K.
(2001). Flagella as a Potential Marker for Campylobacter jejuni Strains Associated with Guillain-Barre Syndrome. J. Clin. Microbiol.
39: 762-764
[Abstract]
[Full Text]